Israel’s ProteKt Therapeutics is developing a treatment for early stage Alzheimer’s disease. It inhibits the PKR enzyme that is over-expressed in Alzheimer’s patients and may slow or even reverse the progress of the disease. It also has potential for ALS, … Continue reading →

As reported previously (Feb 2019) Microsoft’s Israeli R&D team developed the Microsoft Healthcare AI virtual medical assistant. Team leader Hadas Bitran describes the project. They are now working on the New Hope project to match patients with clinical trials around … Continue reading →

Dr. Yehuda Sabiner is the first Israeli-born Haredi to graduate from medical school. A member of the Gerrer Hasidic sect, Yehuda enrolled at Israel’s Technion, graduated and will intern at Israel’s Sheba Medical Center. 35 Haredim are now following in … Continue reading →

A team of over 50 researchers at Harvard University and Tel Aviv University (TAU) have successfully built human “organs-on-chips” that aim to speed up trials of new treatments. They have linked 10 chips together to form a “functional human Body-on-Chips … Continue reading →

Israel and Italy are to launch a satellite in March, on which medical research will be conducted in zero gravity. The mission involves Israel’s SpacePharma (see here), Israel’s Technion, Sheba hospital, the Hebrew University and the Israeli and Italian space … Continue reading →

Israel’s CollPlant is partnering with US-based 3D Systems to spur breakthroughs in regenerative medicine. It brings together top 3D-printing technology with Collprint’s bioink technology for 3D bioprinting of tissues and organs. https://ir.collplant.com/press-releases/detail/83/3d-systems-and-collplant-biotechnologies-join-forces-to https://www.3dsystems.com/press-releases/3d-systems-and-collplant-biotechnologies-join-forces-accelerate-breakthroughs

The US FDA previously approved the brain scan software from Israel’s Aidoc (Oct 2018),. It has now approved all four of Aidoc’s AI products, so its comprehensive package can quickly identify and triage both ischemic and hemorrhagic stroke in CT … Continue reading →

Berlin’s caresyntax, has launched an R&D partnership with the ARC (Accelerate, Redesign, Collaborate) complex at Israel’s Sheba Medical Center. They will use Artificial Intelligence to develop algorithms for predicting responses and outcomes for cancer treatment procedures. https://www.businesswire.com/news/home/20200107005204/en/caresyntax-ARC-Sheba-Medical-Center-Launch-Collaboration https://caresyntax.com/news/caresyntax-sheba-medical-launch-collaboration/

Tel Aviv University represented Israel on World Cancer day as one of five European cities simultaneously broadcasting news of the latest technological developments in cancer diagnosis and treatment. The event was sponsored by the NOBEL Project, which is revolutionizing healthcare … Continue reading →

The European Commission has just granted Orphan drug status to the BL-8040 (Motixafortide) pancreatic cancer treatment from Israel’s BioLineRX (see here). BioLineRX can now receive benefits including EU funding, less regulation, and market exclusivity. https://ir.biolinerx.com/news-releases/news-release-details/biolinerx-receives-orphan-drug-designation-motixafortide-bl-8040